Investor Relations

NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications.

Latest Financial Results

Q3 2021

Quarter Ended Sep 30, 2021

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2020

Company Overview

NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.

IR Contacts

Headquarters

NEXGEL, Inc.
2150 Cabot Boulevard West
Suite B
Langhorne, PA 19407
T: 215-702-8550
info@nexgel.com

Investor Relations

KCSA Strategic Communications
T: 212-896-1254

Valter Pinto
valter@kcsa.com

Nick Staab
nstaab@kcsa.com

Transfer Agent

Continental Stock Transfer & Trust Company
1 State Street
30th Floor
New York, NY 10004
T: 212-845-3269

Legal Counsel

Quick Law Group P.C.
1035 Pearl Street
Suite 403
Boulder, CO 80302
T: 720-259-3393